MGMT and glioblastoma: Most recently, a Phase III trial (NCT02667587) of Stupp regimen+Nivolumab or Placebo for newly diagnosed enzyme O(6)-methylguanine-DNA methyltransferase (MGMT) methylated GBM was reported.